Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy

Plain-language summary

This study aims to create a patient registry for newborns with epilepsy that begins in the first month of life and requires treatment. It enrolls infants without an identifiable occasional cause or a brain malformation explaining the epilepsy, whose parents are able to complete questionnaires. It is conducted as a study without a phase designation and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Assistance Publique Hopitaux De Marseille

Intervention

Survey

Start date

3/6/2021

Estimated completion

9/1/2032

Countries

France

Related genes

Locations

• Angers, France
• Bordeaux, France
• Brest, France
• Lille, France
• Limoges, France
• Lyon, France
• Marseille, France
• Montpellier, France
• Paris, France
• Paris, France
• Paris, France
• Rennes, France
• Strasbourg, France
• Toulouse, France
• Tours, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Epilepsy beginning before 1 month of life, and requiring the initiation of anti-epileptic treatment
* Without occasional cause
* Without brain malformation explaining epilepsy
* No opposition from parents / guardians
* Possibility for parents to complete parent questionnaires

Exclusion Criteria:

* Neonatal attacks of occasional cause (glycemic disorder, infection, etc.)
* Acquired neonatal epilepsy (post-anoxic encephalopathy, stroke sequelae, etc.)
* Neonatal epilepsy related to a brain malformation